XML 51 R18.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Income Taxes

11. Income taxes

The Company is domiciled in the United Kingdom and is primarily subject to taxation in that country. During the years ended December 31, 2021, 2020 and 2019, the Company recorded no income tax benefits for the net operating losses incurred in the UK in each period due to its uncertainty of realizing a benefit from those items. During the year ended December 31, 2021, 2020 and 2019, the Company recorded a tax provision related to income tax obligations of its operating company in the U.S., which generates a profit for tax purposes.

Loss before provision for income taxes consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

United Kingdom

 

$

(61,182

)

 

$

(33,204

)

 

$

(13,990

)

Foreign

 

 

120

 

 

 

8

 

 

 

 

 

 

$

(61,062

)

 

$

(33,196

)

 

$

(13,990

)

 

 

The income tax provision for the years ended December 31, 2021, 2020 and 2019 is comprised of the following (in thousands):

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Current expense:

 

 

 

 

 

 

 

 

 

 

 

 

United Kingdom

 

$

 

 

$

 

 

$

 

Foreign

 

 

59

 

 

 

7

 

 

 

 

Total current expense:

 

 

59

 

 

 

7

 

 

 

 

Deferred expense (benefit):

 

 

 

 

 

 

 

 

 

 

 

 

United Kingdom

 

 

 

 

 

 

 

 

 

Foreign

 

 

(22

)

 

 

(4

)

 

 

 

Total deferred expense (benefit):

 

 

(22

)

 

 

(4

)

 

 

 

Total income tax expense:

 

$

37

 

 

$

3

 

 

$

 

 

The provision for income taxes for the years ended December 31, 2021, 2020 and 2019 was computed at the United Kingdom statutory income tax rate.

A reconciliation of income tax expense computed at the statutory UK income tax rate to income taxes as reflected in the consolidated financial statements is as follows:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Income taxes at UK statutory rate

 

 

19.00

%

 

 

19.00

%

 

 

19.00

%

R&D expenditure

 

 

(6.67

)%

 

 

(6.69

)%

 

 

(12.37

)%

Change in valuation allowance

 

 

(20.12

)%

 

 

(13.12

)%

 

 

(6.85

)%

Change in UK tax rate

 

 

7.64

%

 

 

 

 

 

 

Other

 

 

(0.13

)%

 

 

0.80

%

 

 

0.22

%

 

 

 

(0.28

)%

 

 

(0.01

)%

 

 

 

 

Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2021, 2020 and 2019 consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Deferred tax assets

 

 

 

 

 

 

 

 

 

 

 

 

Net operating loss carryforwards

 

$

17,742

 

 

$

7,065

 

 

$

2,475

 

Depreciation

 

 

(1,311

)

 

 

(983

)

 

 

(243

)

Non-cash share-based compensation

 

 

2,328

 

 

 

769

 

 

 

161

 

Other

 

 

329

 

 

 

241

 

 

 

(2

)

Total deferred tax assets

 

$

19,088

 

 

$

7,092

 

 

$

2,391

 

Valuation allowance

 

 

(19,062

)

 

 

(7,088

)

 

 

(2,391

)

Net deferred tax assets

 

$

26

 

 

$

4

 

 

$

 

 

 

As of December 31, 2021, 2020 and 2019, the Company had UK net operating loss carryforwards of approximately $71.0 million, $37.1 million and $13.0 million, respectively, that can be carried forward indefinitely, respectively.

Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2021, 2020 and 2019 related primarily to the increases in net operating loss carryforwards and research and development tax credit carryforwards were as follows (in thousands):

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Valuation allowance at beginning of year

 

$

7,088

 

 

$

2,391

 

 

$

1,342

 

Increases recorded to income tax provision

 

 

7,624

 

 

 

4,628

 

 

 

996

 

Exchange difference

 

 

(313

)

 

 

69

 

 

 

53

 

Change in tax rate

 

 

4,663

 

 

 

 

 

 

 

Valuation allowance at end of year

 

$

19,062

 

 

$

7,088

 

 

$

2,391

 

 

Future realization of the tax benefits of existing temporary differences and net operating loss carryforwards ultimately depends on the existence of sufficient taxable income within the carryforward period. As of December 31, 2021, 2020 and 2019, the Company performed an evaluation to determine whether a valuation allowance was needed. The Company considered all available evidence, both positive and negative, which included the results of operations for the current and preceding years. The Company determined that it was not possible to reasonably quantify future taxable income and determined that it is more likely than not the net deferred tax assets will not be realized. Accordingly, the Company maintained a full valuation allowance as of December 31, 2021, 2020 and 2019.

The Company applies the authoritative guidance on accounting for and disclosure of uncertainty in tax positions, which requires the Company to determine whether a tax position of the Company is more likely than not to be sustained upon examination, including resolution of any related appeals of litigation processes, based on the technical merits of the position. For tax positions meeting the more likely than not threshold, the tax amount recognized in the financial statements is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon the ultimate settlement with the relevant taxing authority. There were no material uncertain tax positions as of  December 31, 2021, 2020 and 2019.

The Company will recognize interest and penalties related to uncertain tax positions in income tax expense when in a taxable income position. As of December 31, 2021 and 2020, the Company had no accrued interest or penalties related to uncertain tax positions and no amounts have been recognized in the Company’s statement of operations.

The Company files income tax returns in the UK Generally, the tax years through 2020 remain open to examination. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may still be adjusted upon examination by the UK tax authorities, if such tax attributes are utilized in a future period.

During the second quarter of 2021, the Finance Act 2021 (the Act) was enacted in the United Kingdom.  The Act increases the corporate income tax from 19% to 25% effective April 1, 2023 and enhances the first-year capital allowance on qualifying new plant and machinery assets effective April 1, 2021. The effects on the Company’s existing deferred tax balances have been recorded and is offset by the valuation allowance maintained against the Company’s UK net deferred tax assets.

As of December 31, 2021 and 2020, income taxes on undistributed earnings of the Company’s U.S. subsidiary have not been provided for as the Company plans to indefinitely reinvest these amounts in the U.S. The cumulative undistributed foreign earnings were not material as of December 31, 2021 and 2020.